Paliperidone (as palmitate) 273mg, 410mg, 546mg, 819mg; ext-rel susp for IM inj. Schizophrenia after adequately treated with Invega Sustenna (1-month paliperidone palmitate ext-rel inj susp ...

Paliperidone (as palmitate) 39mg, 78mg, 117mg, 156mg, 234mg; ext-rel susp for IM inj. Establish tolerability with oral paliperidone or oral risperidone prior to initiating. Give by deep deltoid IM ...

INVEGA HAFYERA contains the active ingredient paliperidone palmitate. INVEGA HAFYERA is used to treat schizophrenia in adults (18 years of age and older). For more information, see Section 1.

Do not use Invega Trinza if you know you are allergic to any of its ingredients listed at the end of this leaflet or medicines containing paliperidone (e.g. Invega) or risperidone (e.g. Risperdal).

The FDA has just approved Janssen's Invega Hafyera (paliperidone), a twice-yearly injectable formulation that extends the company's big-selling brand and offers the fewest doses per year of any ...

That includes Johnson & Johnson's blockbuster Invega (paliperidone) range, which includes once-monthly (Invega Sustenna), three-monthly (Invega Trinza) and six-monthly version (Invega Hafyera), as ...